Count | |
| 1 | |
| 1 | |
| 3 | |
| 3 | |
| 4 | |
| 2 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 1 | |
| 2 | |
| 1 | |
| 1 | |
alpha-MSH/*analogs & derivatives/metabolism/*therapeutic use | 1 |
| 1 | |
| 1 | |
alpha-MSH/*analogs & derivatives/biosynthesis/*pharmacology/physiology | 1 |
alpha-MSH/administration & dosage/*analogs & derivatives/pharmacology | 1 |
alpha-MSH/analogs & derivatives/chemistry/metabolism/pharmacology | 1 |
alpha-MSH/*analogs & derivatives/chemical synthesis/*pharmacology | 1 |
alpha-Tocopherol/administration & dosage/*analogs & derivatives | 1 |
alpha-MSH/analogs & derivatives/antagonists & inhibitors/metabolism | 1 |
15-Hydroxy-11 alpha,9 alpha-(epoxymethano)prosta-5,13-dienoic Acid | 16 |
| 1 | |
| 2 | |
| 1 | |
| 6 | |
| 15 | |
| 5 | |
| 2 | |
| 10 | |
| 2 | |
| 5 | |
| 1 | |
| 4 | |
| 12 | |
| 9 | |
| 3 | |
| 5 | |
| 1 | |
| 1 | |
| 11 | |
| 6 | |
| 2 | |
| 44 | |
| 1 | |
| 2 | |
| 1 | |
| 15 | |
| 4 | |
| 10 | |
| 1 | |
| 8 | |
| 3 | |
| 5 | |
| 1 | |
| 2 | |
| 1 | |
| 6 | |
| 1 | |
| 5 | |
| 10 | |
| 1 | |
| 64 | |
| 17 | |
| 4 | |
| 7 | |
| 1 | |
| 14 | |
| 1 | |
| 1 | |
| 3 | |
| 2 | |
| 4 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 1 | |
| 3 | |
| 1 | |
| 1 | |
| 9 | |
| 1 | |
| 16 | |
| 1 | |
| 8 | |
| 1 | |
| 3 | |
| 1 | |
| 2 | |
| 22 | |
| 1 | |
| 12 | |